Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y. Graham

Showing results (71-80 of 373) with videos related to

Pageof 38
Sort By:
European Journal of Gastroenterology & Hepatology|June 20, 2013
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from ChinaHong Lu, Wei Zhang, David Y Graham
Seminars in Cancer Biology|July 24, 2013
Eradication of gastric cancer is now both possible and practicalAkiko Shiotani, Putao Cen, David Y Graham
Drugs|April 18, 2008
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyondDavid Y Graham, Hong Lu, Yoshio Yamaoka
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
PCR detection of Helicobacter pylori in clinical samplesEmiko Rimbara, Masanori Sasatsu, David Y Graham
Helicobacter|November 16, 2010
Strategy for eliminating gastric cancer in JapanMasahiro Asaka, Mototsugu Kato, David Y Graham
Digestive Diseases and Sciences|October 3, 2014
Age, period, and cohort effects on gastric cancer mortalityConstance Wang, Ann Weber, David Y Graham
World Journal of Gastroenterology|September 11, 2014
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) centuryTony Trang, Johanna Chan, David Y Graham
Helicobacter|November 16, 2018
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPIDavid Y Graham, Hong Lu, Maria Pina Dore
Helicobacter|April 21, 2012
Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cellsFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Clinics in Laboratory Medicine|March 8, 2005
Molecular markers in Helicobacter pylori-associated gastric carcinogenesisAdrian Gologan, David Y Graham, Antonia R Sepulveda
Pageof 38

Showing results (71-80 of 373) with videos related to

Sort By:
Pageof 38
European Journal of Gastroenterology & Hepatology|June 20, 2013
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from ChinaHong Lu, Wei Zhang, David Y Graham
Seminars in Cancer Biology|July 24, 2013
Eradication of gastric cancer is now both possible and practicalAkiko Shiotani, Putao Cen, David Y Graham
Drugs|April 18, 2008
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyondDavid Y Graham, Hong Lu, Yoshio Yamaoka
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
PCR detection of Helicobacter pylori in clinical samplesEmiko Rimbara, Masanori Sasatsu, David Y Graham
Helicobacter|November 16, 2010
Strategy for eliminating gastric cancer in JapanMasahiro Asaka, Mototsugu Kato, David Y Graham
Digestive Diseases and Sciences|October 3, 2014
Age, period, and cohort effects on gastric cancer mortalityConstance Wang, Ann Weber, David Y Graham
World Journal of Gastroenterology|September 11, 2014
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) centuryTony Trang, Johanna Chan, David Y Graham
Helicobacter|November 16, 2018
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPIDavid Y Graham, Hong Lu, Maria Pina Dore
Helicobacter|April 21, 2012
Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cellsFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Clinics in Laboratory Medicine|March 8, 2005
Molecular markers in Helicobacter pylori-associated gastric carcinogenesisAdrian Gologan, David Y Graham, Antonia R Sepulveda
Pageof 38